OA
MRNA icon

Operose Advisors’s Moderna MRNA Stock Holding History

Operose Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-400
Closed -$26.7K – 561
2024
Q3 		$26.7K Buy
+400
New +$36.7K 0.01% 362
2023
Q1 		– Sell
-260
Closed -$46.7K – 371
2022
Q4 		$46.7K Buy
260
+200
+333% +$32.7K 0.02% 158
2022
Q3 		$7K Hold
60
– – ﹤0.01% 293
2022
Q2 		$9K Hold
60
– – 0.01% 245
2022
Q1 		$10K Hold
60
– – 0.01% 265
2021
Q4 		$15K Buy
+60
New +$17.5K 0.01% 232

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Operose Advisors's MRNA Position: Q4 2024 in Review

Operose Advisors sold out of Moderna (MRNA) in Q4 2024, closing a stake of 400 shares — an estimated $26.7K sold.

Operose Advisors first reported a position in MRNA in Q4 2021 and held it in 6 quarters. The position peaked at $46.7K in Q4 2022. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Operose Advisors reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Operose Advisors sold 400 Moderna shares in Q4 2024, an estimated $26.7K.
  • Operose Advisors first reported a position in Moderna in Q4 2021 and held it in 6 quarters.
  • Operose Advisors's Moderna position peaked at $46.7K in Q4 2022.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Operose Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.